As an independent student newspaper and the paper of record for the city of Berkeley, the Daily Cal has been communicating important updates during this pandemic. Your support is essential to maintaining this coverage.
As UC Berkeley prepares for an in-person fall reopening, a panel of campus faculty and staff addressed questions and concerns regarding a safe return to work during a Campus Conversation on Tuesday.
Read More…
On April 22, the UC Office of the President, or UCOP, made public a proposed policy that strongly recommends that all UC students, faculty, academic appointees and staff receive the COVID-19 vaccine for fall 2021.
Read More…
Children between 12 to 15 years old may soon be able to receive the Pfizer COVID-19 vaccine, pending approval from the Food and Drug Administration, or FDA, early next week.
Read More…
The Western States Scientific Safety Review Workgroup concluded Saturday that Johnson & Johnson vaccine distribution should resume in the western states.
Read More…
Following the recent suspension of the Johnson & Johnson vaccine across the U.S., the city of Berkeley announced a pause in the administration of the vaccine in accordance with state and federal recommendations.
Read More…
President Joe Biden invoked a partnership between Johnson & Johnson and its pharmaceutical competitor, Merck, to expedite vaccine production and distribution.
Read More…
Amid increasing campus cases of COVID-19, UC Berkeley researchers have collaborated in a biosafety level three facility, or BSL-3, to find therapeutics that would help in treating the SARS-CoV-2 virus.
Read More…
Researchers looked at 274 unique brain scans to develop a new method to diagnose Alzheimer’s Disease, the leading cause of dementia, in live patients.
Read More…
As the race to develop a COVID-19 vaccine ensues, California Gov. Gavin Newsom unveiled coronavirus updates and responses on Monday, touching on topics ranging from case numbers to immunization.
Read More…
Ricardo San Martin, the Sutardja Center’s Alt: Meat Lab Director and Industry Fellow, is working on cultivating Quillaja saponaria — the Chilean soapbark tree — so it can be used in an upcoming COVID-19 vaccine candidate.
Read More…
